JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gruenke, L. D.
Right arrow Articles by Waskell, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gruenke, L. D.
Right arrow Articles by Waskell, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 42, Issue of October 20, 1995 pp. 24707-24718
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
The Stoichiometry of the Cytochrome P-450-catalyzed Metabolism of Methoxyflurane and Benzphetamine in the Presence and Absence of Cytochrome b(5)

(Received for publication, June 26, 1995)

Larry D. Gruenke Krystyna Konopka Marie Cadieu Lucy Waskell

The complete stoichiometry of the metabolism of the cytochrome b(5) (cyt b(5))-requiring substrate, methoxyflurane, by purified cytochrome P-450 2B4 was compared to that of another substrate, benzphetamine, which does not require cyt b(5) for its metabolism. Cyt b(5) invariably improved the efficiency of product formation. That is, in the presence of cyt b(5) a greater percentage of the reducing equivalents from NADPH were utilized to generate substrate metabolites, primarily at the expense of the side product, superoxide.

With methoxyflurane, cyt b(5) addition always resulted in an increased rate of product formation, while with benzphetamine the rate of product formation remained unchanged, increased or decreased. The apparently contradictory observations of increased reaction efficiency but decrease in total product formation for benzphetamine can be explained by a second effect of cyt b(5). Under some experimental conditions cyt b(5) inhibits total NADPH consumption. Whether stimulation, inhibition, or no change in product formation is observed in the presence of cyt b(5) depends on the net effect of the stimulatory and inhibitory effects of cyt b(5). When total NADPH consumption is inhibited by cyt b(5), the rapidly metabolized, highly coupled (50%) substrate, benzphetamine, undergoes a net decrease in metabolism not counterbalanced by the increase in the efficiency (2-20%) of the reaction. In contrast, in the presence of the slowly metabolized, poorly coupled (0.5-3%) substrate, methoxyflurane, inhibition of total NADPH consumption by cyt b(5) was never sufficient to overcome the stimulation of product formation due to an increase in efficiency of the reaction.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. N. Bumpus and P. F. Hollenberg
Investigation of the Mechanisms Underlying the Differential Effects of the K262R Mutation of P450 2B6 on Catalytic Activity
Mol. Pharmacol., October 1, 2008; 74(4): 990 - 999.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zhang, D. Hamdane, S.-C. Im, and L. Waskell
Cytochrome b5 Inhibits Electron Transfer from NADPH-Cytochrome P450 Reductase to Ferric Cytochrome P450 2B4
J. Biol. Chem., February 29, 2008; 283(9): 5217 - 5225.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zhang, S.-C. Im, and L. Waskell
Cytochrome b5 Increases the Rate of Product Formation by Cytochrome P450 2B4 and Competes with Cytochrome P450 Reductase for a Binding Site on Cytochrome P450 2B4
J. Biol. Chem., October 12, 2007; 282(41): 29766 - 29776.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. W. Locuson, L. C. Wienkers, J. P. Jones, and T. S. Tracy
CYP2C9 Protein Interactions with Cytochrome b5: Effects on the Coupling of Catalysis
Drug Metab. Dispos., July 1, 2007; 35(7): 1174 - 1181.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. W. Locuson, J. M. Hutzler, and T. S. Tracy
Visible Spectra of Type II Cytochrome P450-Drug Complexes: Evidence that "Incomplete" Heme Coordination Is Common
Drug Metab. Dispos., April 1, 2007; 35(4): 614 - 622.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Clarke, S.-C. Im, A. Bidwai, and L. Waskell
The Role of the Length and Sequence of the Linker Domain of Cytochrome b5 in Stimulating Cytochrome P450 2B4 Catalysis
J. Biol. Chem., August 27, 2004; 279(35): 36809 - 36818.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Fleming
Cytochrome P450 and Vascular Homeostasis
Circ. Res., October 26, 2001; 89(9): 753 - 762.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. Shultz, D. Morin, A.-M. Chang, and A. Buckpitt
Metabolic Capabilities of CYP2F2 with Various Pulmonary Toxicants and Its Relative Abundance in Mouse Lung Subcompartments
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 510 - 519.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Bridges, L. Gruenke, Y.-T. Chang, I. A. Vakser, G. Loew, and L. Waskell
Identification of the Binding Site on Cytochrome P450 2B4 for Cytochrome b5 and Cytochrome P450 Reductase
J. Biol. Chem., July 3, 1998; 273(27): 17036 - 17049.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. M. Guzov, H. L. Houston, M. B. Murataliev, F. A. Walker, and R. Feyereisen
Molecular Cloning, Overexpression in Escherichia coli, Structural and Functional Characterization of House Fly Cytochrome b5
J. Biol. Chem., October 25, 1996; 271(43): 26637 - 26645.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.